Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's Golden Meditech, Fenwal Of U.S. Form Joint Blood Device Venture

This article was originally published in PharmAsia News

Executive Summary

The Chinese healthcare company Golden Meditech has formed a joint venture with U.S.-based Fenwal, a medical-device maker. The venture, to be located in Beijing, plans to produce blood-collection and tranfusion products for Chinese use. Both Fenwal and Golden Meditech make healthcare products. Fenwal is known for its Amicus cell-separation system to collect platelets and Golden Meditech for its 3000H Plasma Exchange system to remove toxins from blood. The joint venture is expected to be completed early next year with Fenwal owning 51 percent. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel